Details for 2017726442

Up to date per 26.04.2026

Actions

Title / Product Name

HERSTELLUNG VON (S)-N-(5-((R)-2-(2,5-DIFLUOROPHENYL)PYRROLIDIN-1-YL)PYRAZOLO[1,5-A]PYRIMIDIN-3-YL)-3-HYDROXYPYRROLIDINE-1-CARBOXAMIDE

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2017726442

EP Publication Number

3458456

E-Number

1338164

Language

PCT Number

US17033257

Publication Date

27.03.2019 A

25.11.2020 B1

Registration Date

25.11.2020

AT Publication Date

15.12.2020

Application Date

18.05.2017

Registration Number

Priorities

18.05.2016

201662338359 P

IPC

C07D 487/04 20060101AFI20200515BHEP

Maximum Duration of Protection

18.05.2037

Owner

Loxo Oncology, Inc.281 Tresser Boulevard 9th Floor Stamford, Connecticut 06901US

Array Biopharma Inc.3200 Walnut Street Boulder, CO 80301US

Representative

No representatives present

Inventor

REYNOLDS, Mark281 Tresser Blvd. Stamford, CT 06901US

EARY, Charles Todd281 Tresser Blvd. Stamford, CT 06901US

SPENCER, Stacey873 Stagecoach Trail Lyons, CO 80540US

JUENGST, Derrick4529 Canterbury Drive Boulder, CO 80301US

HACHE, Bruno281 Tresser Blvd. Stamford, CT 06901US

JIANG, Yutong3200 Walnut St. Boulder, CO 80301US

HAAS, Julia3200 Walnut St. Boulder, CO 80301US

ANDREWS, Steven W.3200 Walnut St. Boulder, CO 80301US

Information about Fees